424 research outputs found

    Folyami hajózás és a magyarországi gabonaexport

    Get PDF
    Az árutermelésre áttért mezÅ‘gazdaság közel másfél évszázada alatt bebizonyosodott, hogy a megtermelt terményfelesleg az ország gazdaságföldrajzi „bezártsága†miatt nem versenyképes a tengeri kijutással rendelkezÅ‘ országok gabonájával szemben. Atengeri kikötÅ‘höz vezetÅ‘ olcsó vízi utat máig sem sikerült megteremteni, és a magyar gabona jelenleg is csak a világpiaci árnál alacsonyabb áron értékesíthetÅ‘. Afolyók vízjárástól független hajózhatósága azok belépcsÅ‘zésével valósítható meg. ------------------------------------------- Over the one and a half centuries since agriculture shifted from self-sufficiency to producing marketable goods, it has been proven that the surplus produce – due to the country’s geographical isolation – cannot compete against the cereal of countries with access to seas and oceans. We still have not been able to create a cheap water route to a seaport, and Hungarian cereals can still only be sold below world market prices. To make rivers navigable irrespective of the changes to their water levels, weirs are needed.gazdaságföldrajz, bezártság, belvízi hajózás, vízlépcsÅ‘k, eco-geography, isolation, inland navigation, weirs, Agricultural and Food Policy, International Relations/Trade,

    Cochlear implantation of a Hungarian deaf and blind patient with discharging ears suffering from Behçet's disease

    Get PDF
    A case is reported in which a Nucleus 22 channel intracochlear device was implanted a deaf/blind Hungarian adult with discharging ears suffering from Behçet's disease. Preconditioning surgery was employed three months prior to the implantation procedure to ensure a sterile, dry protected environment for the electrodes. One month after implantation, the patient exhibited excellent auditory discrimination capability at the time of the first switch on. We suggest that some deaf/blind individuals may serve as very good candidates for intracochlear implantatio

    The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor

    Get PDF
    Mobilized blood has supplanted bone marrow (BM) as the primary source of hematopoietic stem cells for autologous and allogeneic stem cell transplantation. Pharmacologically enforced egress of hematopoietic stem cells from BM, or mobilization, has been achieved by directly or indirectly targeting the CXCL12/CXCR4 axis. Shortcomings of the standard mobilizing agent, granulocyte colony-stimulating factor (G-CSF), administered alone or in combination with the only approved CXCR4 antagonist, Plerixafor, continue to fuel the quest for new mobilizing agents. Using Protein Epitope Mimetics technology, a novel peptidic CXCR4 antagonist, POL5551, was developed. In vitro data presented herein indicate high affinity to and specificity for CXCR4. POL5551 exhibited rapid mobilization kinetics and unprecedented efficiency in C57BL/6 mice, exceeding that of Plerixafor and at higher doses also of G-CSF. POL5551-mobilized stem cells demonstrated adequate transplantation properties. In contrast to G-CSF, POL5551 did not induce major morphological changes in the BM of mice. Moreover, we provide evidence of direct POL5551 binding to hematopoietic stem and progenitor cells (HSPCs) in vivo, strengthening the hypothesis that CXCR4 antagonists mediate mobilization by direct targeting of HSPCs. In summary, POL5551 is a potent mobilizing agent for HSPCs in mice with promising therapeutic potential if these data can be orroborated in humans

    25 years of epidermal stem cell research.

    Get PDF
    This is a chronicle of concepts in the field of epidermal stem cell biology and a historic look at their development over time. The past 25 years have seen the evolution of epidermal stem cell science, from first fundamental studies to a sophisticated science. The study of epithelial stem cell biology was aided by the ability to visualize the distribution of stem cells and their progeny through lineage analysis studies. The excellent progress we have made in understanding epidermal stem cell biology is discussed in this article. The challenges we still face in understanding epidermal stem cells include defining molecular markers for stem and progenitor sub-populations, determining the locations and contributions of the different stem cell niches, and mapping regulatory pathways of epidermal stem cell proliferation and differentiation. However, our rapidly evolving understanding of epidermal stem cells has many potential uses that promise to translate into improved patient therapy

    Concealed expansion of immature precursors underpins acute burst of adult HSC activity in foetal liver

    Get PDF
    One day prior to mass emergence of haematopoietic stem cells (HSCs) in the foetal liver at E12.5, the embryo contains only a few definitive HSCs. It is thought that the burst of HSC activity in the foetal liver is underpinned by rapid maturation of immature embryonic precursors of definitive HSCs, termed pre-HSCs. However, because pre-HSCs are not detectable by direct transplantations into adult irradiated recipients, the size and growth of this population, which represents the embryonic rudiment of the adult haematopoietic system, remains uncertain. Using a novel quantitative assay, we demonstrate that from E9.5 the pre-HSC pool undergoes dramatic growth in the aorta-gonad-mesonephros region and by E11.5 reaches the size that matches the number of definitive HSCs in the E12.5 foetal liver. Thus, this study provides for the first time a quantitative basis for our understanding of how the large population of definitive HSCs emerges in the foetal liver

    Effect of hypercholesterolemia on myocardial function, ischemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning

    Get PDF
    Hypercholesterolemia is considered to be a principle risk factor for cardiovascular disease, having direct negative effects on the myocardium itself, in addition to the development of atherosclerosis. Since hypercholesterolemia affects global cardiac gene expression profile, among many other factors, increased myocardial oxidative stress, mitochondrial dysfunction and inflammation trigger apoptosis and this may account for myocardial dysfunction and increased susceptibility of the myocardium to infarction. In addition, numerous experimental and clinical studies revealed that hyperlcholesterolemia may interfere with the cardioprotective potential of conditioning mechanisms. Although not fully elucidated, the underlying mechanisms for the lost cardioprotection in hypercholesterolemic animals have been reported to involve dysregulation of eNOS-cGMP, RISK, peroxynitrite-MMP2 signaling pathways, modulation of KATP channels and apoptotic pathways. In this review article, we summarize current knowledge on the effect of hypercholesterolemia on the non-ischemic and ischemic heart as well as on the cardioprotection induced by drugs or ischemic preconditioning (PC), postconditioning (PostC) and remote conditioning. We also summarize the effects of hypercholesterolemia on drug-induced cardioprotection, in the presence of hypercholesterolemia. Future perspectives concerning the mechanisms and the design of pre-clinical and clinical trials are highlighted
    corecore